Cargando…

Multimodal short acting sedation using NMDA antagonist and remifentanil in brain trauma patients: a prospective randomised study

Detalles Bibliográficos
Autores principales:	Meurant, F, Ahdach, Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095477/ http://dx.doi.org/10.1186/cc5584

Ejemplares similares

Remifentanil versus sufentanyl narco-sedation in a surgical and medical critical care unit with prevention of narcotic-induced hyperalgesia: a randomized double blind study
por: Meurant, F
Publicado: (2006)

Remifentanil for postoperative analgo-sedation: effects on glycaemia and HOMA score
por: Chelazzi, C, et al.
Publicado: (2010)

Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
por: Al, M, et al.
Publicado: (2007)

Decreased time on mechanical ventilation using remifentanil-based analgesia and sedation
por: Malbrain, M, et al.
Publicado: (2004)

Remifentanil versus sufentanil continuous infusion for sedation in mechanically ventilated patients
por: Costa, G, et al.
Publicado: (2005)

Remifentanil-based analgesia and sedation facilitates more rapid and predictable time to neurological assessments
por: Karabinis, A, et al.
Publicado: (2004)

Weaning from mechanical ventilation using remifentanil versus midazolam–morphine analgo sedation: our experience
por: Nardo, M Di, et al.
Publicado: (2005)

Sparing analgesic effect using pregabaline in postsurgical trauma patients in the ICU
por: Meurant, F, et al.
Publicado: (2006)

Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
por: Karabinis, A, et al.
Publicado: (2004)

Economic evaluation of remifentanil-based versus conventional sedation for patients with an anticipated mechanical ventilation duration of 2–3 days in Germany
por: Al, MJ, et al.
Publicado: (2008)

Assessment of stress oxidative modulation when conventional parenteral solutions were used compared with nutrition based on an olive oil compound in multiple trauma patients
por: Meurant, F, et al.
Publicado: (2006)

Introduction of a remifentanil-based analgo-sedation protocol leads to a reduction of duration of mechanical ventilation and ICU stay in critically ill patients
por: Van den Bosch, J, et al.
Publicado: (2011)

Remifentanil in neurosurgical patients in the intensive care unit
por: Koukoulitsios, G, et al.
Publicado: (2005)

Dexmedetomidine for short-term and long-term sedation: amplifying its applicability
por: Beer, I, et al.
Publicado: (2005)

Remifentanil dosage in critically ill patients is independent of organ dysfunction
por: Kulier, A, et al.
Publicado: (2006)

The place for short-acting opioids: special emphasis on remifentanil
por: Wilhelm, Wolfram, et al.
Publicado: (2008)

Application of remifentanil for conscious sedation and analgesia in short-term ERCP and EST surgery
por: Sun, Guo-Qiang, et al.
Publicado: (2017)

BIS and spectral entropy monitoring during sedation with midazolam/remifentanil and dexmedetomidine/remifentanil
por: Absalom, Anthony R, et al.
Publicado: (2009)

The safety of remifentanil administered for up to 5 days in ICU patients with neurotrauma
por: Stergiopoulos, S, et al.
Publicado: (2004)

Effect of low-dose ketamine regimen with or without magnesium sulphate adjunct in tramadol patient controlled analgesia in a major abdominal surgery ICU population
por: Meurant, F, et al.
Publicado: (2009)

Additional sedative drugs to light sedation with dexmedetomidine is risk for delirium
por: Sakuraya, M, et al.
Publicado: (2015)

Sedation in haemofiltered patients: a retrospective study of compliance with the sedation policy
por: Al-Saffar, S, et al.
Publicado: (2005)

The Richmond agitation–sedation scale and bispectral index during dexmedetomidine sedation
por: Turkmen, A, et al.
Publicado: (2005)

Sedation during mechanical ventilation: a comparison of sedatonarcosis and awake sedation
por: Völgyes, B, et al.
Publicado: (2008)

Physical interactions between D1 and NMDA receptors as a possible inhibitory mechanism to avoid excessive NMDA currents
por: Smith, Daniel B, et al.
Publicado: (2007)

Sedation practices in Denmark
por: Espersen, K, et al.
Publicado: (2007)

Comparison of the RAMSAY score and the Richmond Agitation Sedation Score for the measurement of sedation depth
por: Riessen, R, et al.
Publicado: (2012)

Simulation of AMPA and NMDA contribution to postsynaptic response
por: Galindo, Crhistian Miguel Gutiérrez, et al.
Publicado: (2015)

Remifentanil target-controlled infusion for fiberoptic bronchoscopy in the ICU: feasability, safety and tolerance evaluation
por: Caron, M, et al.
Publicado: (2015)

Safety and efficacy of a nurse-driven sedation protocol with daily sedation interruption in the ICU
por: Chan, KP, et al.
Publicado: (2010)

Procedural sedation in the emergency department
por: Shah, MS, et al.
Publicado: (2013)

Multiparametric evaluation of sedation in the ICU
por: Donati, A, et al.
Publicado: (2008)

Expression and roles of glutamate (NMDA) receptors on T cell subsets
por: Orihara, Kanami, et al.
Publicado: (2010)

Risk and benefit of protocol sedation and daily interruption of sedation for mechanically ventilated patients: a systematic review
por: Hosokawa, K, et al.
Publicado: (2013)

Assessment of sedation in patients with pressure-controlled ventilation: tidal-volume variance, sedation scores or bispectral index?
por: Huber, W, et al.
Publicado: (2006)

Remifentanil for analgesia-based sedation in the intensive care unit
por: Kuhlen, Ralf, et al.
Publicado: (2004)

Dopamine-NMDA interactions and relevance to gamma band synchrony in schizophrenia
por: Kömek, Kübra, et al.
Publicado: (2013)

Addition of propofol, midazolam, or haloperidol to sufentanil for intravenous sedation in the ICU using the bispectral index
por: Tukenmez, B, et al.
Publicado: (2006)

Short-term sedation of mechanically ventilated ICU patients with propofol, benzodiazepines, or dexmedetomidine: systematic review and meta-analysis on awakening and recovery times
por: Feuersenger, A, et al.
Publicado: (2015)

PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy
por: Vermeersch, SGG, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vf6i5h1n27g4tf80bgnhu03tm8